Vaccine also referred to as human vaccine, as defined by WHO, is a biological preparation that improves immunity to a particular disease. It contains an agent that resembles a disease causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. Human body has natural ability to learn about eliminating all sorts of germs or microbes that cause diseases. Vaccine utilizes that ability of the body to enable it to protect itself, from those microbes, which have attacked it before. Typically, vaccines are administered through injections, orally and sprayed into the nose. Human vaccines are of two types such as preventable and therapeutic vaccines. According to report the global vaccine market was sized over USD 29.17 billion in 2016. The global vaccine market is projected to grow with a CAGR 5.2% in terms of value during the forecast period, 2017-2023 and reach USD 41.87 billion by 2023.
High prevalence of infectious diseases is the primary factor driving the growth in the global market for vaccines. Moreover, the government support for the development of vaccines is likely to augment the growth in the market over the next six years. Moreover, and increasing investments in the research and development of new vaccines is expected to accelerate the growth in the vaccine market over the forecast period. On the other hand, high cost associated with development of vaccines is the primary restraining factor hampering the growth in the market over the forecast period. Government initiatives in emerging markets and economic development in emerging markets of Asia, Latin America and Africa to augment the healthcare expenditure per capita and new vaccines in pipeline are likely to provide opportunities for the companies operating in the global vaccines market.
The report on global vaccine market covers segments such as type, and application. The type segments include DNA vaccines, conjugate vaccines, live attenuated vaccines, inactivated vaccines, toxoid vaccines, subunit vaccines, and others. On the basis of application, the global vaccine market is categorized into allergy, autism, cancer, infectious diseases, and others.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015 – 2023. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea and Malaysia among others. Moreover, The European region covers countries such as, Germany, UK, France, Spain and Rest of Europe. Emerging markets of Asia-Pacific, Africa and Latin America regions are expected to drive the growth in the world market. The Asia-Pacific region is expected to grow at a CAGR of 6.99% over the forecast period. The fast growth in India and China are the key factors promoting to swift CAGR growth in the region over the period of 2017 to 2023.
The report provides profiles of the companies in the global vaccine market such as, Mitsubishi Tanabe, AstraZeneca, Merck & Co. Inc, GlaxoSmithKline plc (GSK), Pfizer Inc., SANOFI S.A, NOVARTIS AG, Takeda Pharmaceuticals, Astellas Pharma Inc., and Emergent BioSolutions.
The report provides deep insights on demand
forecasts, market trends and micro and macro indicators. In addition, this report
provides insights on the factors that are driving and restraining the Global
Vaccine Market. Moreover, IGR-Growth Matrix analysis given in the report brings
an insight on the investment areas that existing or new market players can
consider. The report provides insights into the market using analytical tools
such as Porter’s five forces analysis and DRO analysis of vaccine market.
Moreover, the study highlights current market trends and provides forecast from
2017 to 2023. We also have highlighted future trends in the Vaccine Market that
will impact the demand during the forecast period. Moreover, the competitive
analysis given in each regional market brings an insight on the market share of
the leading players. Additionally, the analysis highlights rise and fall in the
market shares of the key players in the market. This report will help
manufacturers, suppliers and distributors of the vaccine market to understand
the present and future trends in this market and formulate their strategies
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter